Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.
To support increased capacity for surveillance of antimicrobial resistance in selected lower-middle-income countries (LMICs).
Thank you for sharing.
Foundation for Innovative New Diagnostics
$500,000
24 months
Improving Surveillance for Antimicrobial Resistance
Nov 2021
Creating positive outcomes for future generations.
